AzTrials
AzTrials

Premature InfantGuidelineNCT07052786

Development and Effectiveness Evaluation of a Clustered Care Guideline Within Individualized Developmental Care: RCT

A study testing Infants will receive group care based on individualized developmental care according to the guide. in people with Premature Infant and Clustered Care, run by KTO Karatay University at 1 site in Turkey (Türkiye).

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The Individualized Developmental Care (IDC) model was developed to minimize the negative impact of the neonatal intensive care environment and to support infants' physiological stability. Read more about this study

Who is it for?
Any age, women onlyHealthy volunteers can take part
What is being tested?
Infants will receive group care based on individualized developmental care according to the guide.
Could I receive a placebo?
No, everyone receives an active treatment
How many people
49 participants
Where
1 siteTurkey (Türkiye)
Study dates
1 Jul 2025to 15 Jan 2026
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • Women only
  • Healthy volunteers accepted
  • Child, Adult, Older adult

Who may be able to join

  • Working in the NICU of Necmettin Erbakan University Medical Faculty Hospital,
  • Having at least 3 months of experience in the NICU,
  • Volunteering to participate in the research.

Who cannot join

  • The nurse wanting to leave the study during the study
  • The nurse not participating in the training or not completing the training
  • The nurse not being able to complete the study, including the final

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Meram Faculty of Medicine

    Konya

Other trials in Turkey (Türkiye)

About this study

The Individualized Developmental Care (IDC) model was developed to minimize the negative impact of the neonatal intensive care environment and to support infants' physiological stability. It supports the practice of clustered care, which refers to grouping routine medical and nursing procedures into a single care time period to reduce handling and allow the infant uninterrupted rest and maintenance of the sleep-wake cycle.

This study aims to develop a clustered care practice guideline and evaluate its effectiveness. The study was designed as a single-blind randomized controlled trial, where the participating nurses will not be informed about their group allocation (intervention or control) to reduce bias.The study will be conducted between July and September 2025 in the level 2 and 3 NICUs of Necmettin Erbakan University Faculty of Medicine Hospital in Konya, Turkey.

Read more

The study population includes all 44 nurses working in these NICUs who meet the inclusion criteria and agree to participate. Since the entire population is accessible, total population sampling will be used. After data collection is completed, a post hoc power analysis will be conducted using G*Power (v3.1.9.2).

Data will be collected using the "Descriptive Information Form for the Infant and the Nurse" and the "Clustered Care Practice Guideline". Pre-test data will be collected before training, and post-test data will be collected 4-6 weeks after the training.

The intervention group will receive the Clustered Care Practice Training Based on Individualized Developmental Care in two in-person sessions (approx. 45 minutes per session), delivered in small groups (11-12 participants). A training booklet prepared by the researchers will be distributed at the end of the sessions.

The normality of the data will be assessed using the Kolmogorov-Smirnov test, normal distribution curves, and skewness-kurtosis values. Parametric tests will be used for normally distributed data; non-parametric tests will be used otherwise. A significance level of P<0.05 will be applied.

Ethical approval was obtained from the Ethics Committee of KTO Karatay University Pharmaceutical and Medical Research (decision no: 2022/014, date: 21.06.2022). Institutional permission was obtained from NEU Faculty of Medicine Hospital. Written informed consent will be obtained from all participating nurses and from parents of the observed infants.

Read the detailed description

Premature infants require intensive care during the early stages of life due to their physiological immaturity and heightened sensitivity to environmental stimuli. Routine care practices commonly performed in neonatal intensive care units (NICUs) may negatively affect the comfort and physiological stability of these infants. Therefore, individualized and developmentally supportive care practices tailored to the specific needs of premature infants have become essential.

This randomized controlled trial aims to evaluate the effectiveness of a clustered care practice guideline developed in accordance with individualized developmental care principles. The study will be conducted with nurses working in a neonatal intensive care unit. Nurses will be randomly assigned to either an intervention group or a control group.

The intervention group will receive training on the use of a clinical guideline designed to implement clustered care based on individualized developmental care, while the control group will continue to provide standard routine care. The effectiveness of the intervention will be assessed through the average scores obtained from the use of the guideline and a qualitative analysis of nurses' perspectives. This study is expected to highlight the importance of developmental care approaches in nursing and contribute to enhancing the overall quality of care provided in NICUs.

Being tested
Infants will receive group care based on individualized developmental care according to the guide., Standard care
Keywords
clustered care, guideline,nurse, NICU
Medical subject headings
Premature Birth

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Infants will receive group care based on individualized developmental care according to the guide.Behavioural

    Also called Care based on guidelines

    A guide to implementing group care based on individualized developmental care will be developed, and nurses working in the NICU will be trained in group care practices and how to use the guide.

  • Standard careBehavioural

    Nurses working in the NICU will continue to provide standard care. After the study is completed, nurses in the control group will also receive the same training as the other group.

Study groups in NCT07052786
Study groupRoleWhat they receive
ExperimentalExperimentalIndividualized developmental care-based group care will be provided to infants according to the guidelines.
Receives: Behavioral: Infants will receive group care based on individualized developmental care according to the guide.
Control groupActive comparatorInfants will receive routine care.
Receives: Behavioral: Standard care

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Nurse behavior change

    Measured by test score change from pre- to post-test within 6 weeks Research literature generally classifies observation methods into three types: participant observation, non-participant observation, and covert observation. In this study, a structured, direct, non-participant observation method was used to observe the care practices of nurses working in the neonatal intensive care unit in accordance with the developed Clustered Care Implementation Guide. Each nurse was observed twice during the designated care times-once during the pre-test and once during the post-test-with respect to the care practices they performed.

    To minimize the risk of observer bias, the Clustered Care Implementation Guide was used as a structured observation form. The care stages were predefined according to the routine clinical workflow, and only the practices, behaviours, and responses that were actually observed were recorded in the guide; no subjective interpretations or comments were added. Throughout

    Measured: within 6 weeks

Secondary outcomes (1)
  1. Nurses' opinions on the effectiveness of the clinical guideline

    Evaluation of nurses' perceptions regarding the effectiveness, applicability, and usability of the individualized developmental clustered care guideline.

    The scoring is based on the 4-point Likert-type assessment section of the 55-item Clustered Care Implementation Guide. In the scoring process, the "performed" option is scored as 1, whereas the "not performed despite being required" option is scored as 0. The "not performed because it was not required" and "not applicable" options are marked during care provision but are excluded from the scoring. For example, if five items are marked as "not performed because it was not required" or "not applicable," the total score is calculated based on 50 rather than 55 items. If 48 of the remaining 50 items are scored as 1, the percentage of items marked as "performed" represents the score obtained from the guide.Since this is a clinical practice guide rather than a scale, no cut-off value has been established. A higher total score on the guide.

    Measured: 4-6 weeks post-intervention

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted7 Jul 2025
  2. Study start1 Jul 2025
  3. Primary completion1 Nov 2025
  4. Study completion15 Jan 2026

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
49 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07052786
Sponsor's protocol ID
2022/014
Acronym
Guideline
Status last verified
Aug 2026
First submitted
23 Jun 2025
Last updated
19 Aug 2026
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: Confidentiality

Questions about this trial

What is this clinical trial studying?

A study testing Infants will receive group care based on individualized developmental care according to the guide. in people with Premature Infant and Clustered Care, run by KTO Karatay University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 19 Aug 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Nurse behavior change (time frame: within 6 weeks). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Aug 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in